← Leaderboards
Molly A Hughes
University Of Virginia Charlottesville
$6,444,579
Attributed
$6,444,579
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $631K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,444,579 · 8
By mechanism
R01$4,619,915 · 2
R21$1,427,935 · 3
K08$366,729 · 1
R13$30,000 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- David M. Lyerly$2,329,818
- Barbara J Mann$2,728,160
- Joel M. Linden$14,399,863
- Tracy D. Wilkins$152,718
- Thomas J Braciale$22,435,148
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenAntibioticsInfectionBaseFoundationsMediatingBacteriaResistanceIn VivoPhenotypeExhibitsInsightReceptorInnovationInvadedMulti-Drug ResistanceIn VitroCellsLeadLifeBiologicalImmuneHost DefenseMicroorganism
Grant awards (20)
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria$614,218
R01 · FY2024 · AI · contact PI
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria$613,109
R01 · FY2023 · AI · contact PI
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria$606,542
R01 · FY2022 · AI · contact PI
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria$630,959
R01 · FY2021 · AI · contact PI
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria$598,787
R01 · FY2020 · AI · contact PI
Elucidating a unique bacterial strategy that protects susceptible bacteria from antibiotic killing and promotes the genetic transmission of antimicrobial resistance$245,777
R21 · FY2019 · AI · contact PI
Elucidating a unique bacterial strategy that protects susceptible bacteria from antibiotic killing and promotes the genetic transmission of antimicrobial resistance$205,298
R21 · FY2018 · AI · contact PI
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity$395,000
R01 · FY2016 · AI · contact PI
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity$395,000
R01 · FY2015 · AI · contact PI
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity$395,000
R01 · FY2014 · AI · contact PI
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity$371,300
R01 · FY2013 · AI · contact PI
2011 Chemical & Biological Terrorism Defense Gordon Research Conference (GRC) and$15,000
R13 · FY2011 · AI · contact PI
Innate Immune Recognition of B. anthracis$189,375
R21 · FY2009 · AI · contact PI
2009 Chemical and Biological Terrorism Defense Gordon Research Conference$15,000
R13 · FY2009 · AI · contact PI
Innate Immune Recognition of B. anthracis$227,250
R21 · FY2008 · AI · contact PI
Studies on Macrophage Resistance to Anthrax Lethal Toxin$266,219
R21 · FY2004 · AI
Identification of E. histolytica virulence factors$122,243
K08 · FY2004 · AI
Studies on Macrophage Resistance to Anthrax Lethal Toxin$294,016
R21 · FY2003 · AI
Identification of E. histolytica virulence factors$122,243
K08 · FY2003 · AI
Identification of E. histolytica virulence factors$122,243
K08 · FY2002 · AI